Financial Advocates Investment Management cut its position in Relx Plc (NYSE:RELX – Free Report) by 55.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,400 shares of the technology company’s stock after selling 8,044 shares during the quarter. Financial Advocates Investment Management’s holdings in Relx were worth $291,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of RELX. Bleakley Financial Group LLC lifted its holdings in shares of Relx by 12.4% during the 4th quarter. Bleakley Financial Group LLC now owns 13,940 shares of the technology company’s stock valued at $633,000 after purchasing an additional 1,542 shares during the last quarter. Choreo LLC increased its position in Relx by 3.6% during the 4th quarter. Choreo LLC now owns 20,106 shares of the technology company’s stock valued at $913,000 after buying an additional 702 shares in the last quarter. Money Concepts Capital Corp acquired a new position in Relx during the 4th quarter valued at about $210,000. Calamos Advisors LLC purchased a new stake in Relx in the fourth quarter valued at about $561,000. Finally, CENTRAL TRUST Co boosted its holdings in Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after acquiring an additional 529 shares in the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities analysts have recently issued reports on the stock. Redburn Atlantic assumed coverage on shares of Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock. StockNews.com began coverage on shares of Relx in a research note on Wednesday, October 30th. They set a “hold” rating on the stock.
Relx Stock Performance
Shares of RELX stock opened at $49.98 on Monday. The business has a fifty day moving average of $47.45 and a 200 day moving average of $46.98. Relx Plc has a 1 year low of $40.25 and a 1 year high of $50.84. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.42 and a current ratio of 0.48.
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Further Reading
- Five stocks we like better than Relx
- Investing in Travel Stocks Benefits
- 3 Volatility ETFs to Help You Profit from Market Chaos
- What Are Dividend Champions? How to Invest in the Champions
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- 3 Best Fintech Stocks for a Portfolio Boost
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.